{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:45:19Z","timestamp":1775846719139,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmi.2025.12.019","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:08:26Z","timestamp":1767168506000},"page":"853-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and clinical implication of trimethoprim\/sulfamethoxazole susceptibility discrepancy between VITEK-2 and disc diffusion testing methods in Central Australia"],"prefix":"10.1016","volume":"32","author":[{"given":"Georgia","family":"Cramp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Mcleod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.12.019_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12879-017-2460-3","article-title":"High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA","volume":"17","author":"Harch","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.019_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-4842-1","article-title":"Antibiotic use among twelve Canadian First Nations communities: a retrospective chart review of skin and soft tissue infections","volume":"20","author":"Jeong","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.019_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-021-00964-1","article-title":"Antimicrobial stewardship in rural and remote primary health care: a narrative review","volume":"10","author":"Yau","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2025.12.019_bib4","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","author":"Stevens","year":"201459147","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.019_bib5","series-title":"Therapeutic guidelines","year":"2025"},{"key":"10.1016\/j.cmi.2025.12.019_bib6","article-title":"Investigation of trimethoprim\/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting","author":"Harris","year":"2018241027","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.12.019_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1017\/ice.2022.9","article-title":"Trimethoprim-sulfamethoxazole resistance patterns among Staphylococcus aureus in the United States, 2012\u20132018","volume":"44","author":"Ham","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2025.12.019_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00651-20","article-title":"Clinical and molecular epidemiology of an emerging panton-valentine leukocidin-positive ST5 methicillin-resistant Staphylococcus aureus clone in Northern Australia","volume":"6","author":"McGuinness","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2025.12.019_bib9","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/imj.16548","article-title":"The heart of the matter: a re-iteration of the role of the social determinants of health in addressing health inequity in Central Australia","volume":"54","author":"Naughton","year":"2024","journal-title":"Intern Med J"},{"key":"10.1016\/j.cmi.2025.12.019_bib10","series-title":"Performance standards for antimicrobial susceptibility testing. 20th informational supplement CLSI M100-S20","year":"2010"},{"key":"10.1016\/j.cmi.2025.12.019_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/1469-0691.12702","article-title":"Staphylococcus aureus \u2018Down under\u2019: contemporary epidemiology of S. aureus in Australia, New Zealand, and the South west Pacific","volume":"20","author":"Williamson","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.12.019_bib12","series-title":"Book central Australian health service Antibiogram 2023","year":"2023"},{"key":"10.1016\/j.cmi.2025.12.019_bib13","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1093\/jac\/dkz361","article-title":"Sulfamethoxazole\/trimethoprim resistance overcall by VITEK\u00ae 2 and BD Phoenix\u2122 in community-associated MRSA and MSSA","volume":"74","author":"Coombs","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:45:33Z","timestamp":1775843133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25006305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1198743X25006305"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.12.019","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and clinical implication of trimethoprim\/sulfamethoxazole susceptibility discrepancy between VITEK-2 and disc diffusion testing methods in Central Australia","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}